Micronutrient Imbalance and Common Phenotypes in Neural Tube Defects
Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States
The current study uses therapeutic trial results in combination with pricing evaluations and healthcare records to demonstrate unequal patient access to these medications
Rouhana, S., Virsolvy, A., Fares, N., Richard, S., & Thireau, J
With that caveat, here is what the published Phase 3 data say at peak dose, in adults with obesity and without diabetes: The roughly 6-percentage-point gap between retatrutide and tirzepatide at peak dose, sustained across more than 2,000 participants, is the data point payers and prescribers will spend the next year arguing about